688513.SH
Chengdu Easton Biopharmaceuticals Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 42.91
−5.82%Sep 7, 2026, 09:33 UTC
Yuandong Biologics announced it will repurchase and cancel 257,454 shares of its 2024 employee stock ownership plan that failed to unlock in the second vesting period, at a repurchase price of 21.63 yuan per share, reducing total shares from 176,532,300 to 176,274,800.
Source:Aug 31, 2026, 09:29 UTC
Yuandong Biologics announced that as of the end of August 2026, it had repurchased 1,386,528 shares (0.7854% of total share capital) for a total amount of 60.7535 million yuan, within its buyback program running from June 4 to September 3, 2026.
Source:Aug 20, 2026, 09:20 UTC
Yuandong Biologics announced its first-half 2026 results: revenue of 659 million yuan, net profit down 4.99% year-on-year.
Source:Aug 20, 2026, 09:20 UTC
Yuandong Biological announced the termination of its biological drug research project, with remaining raised funds of 100 million yuan to be permanently used as working capital.
Source: